排石汤对肾结石手术治疗患者的疗效研究

doi:10.3760/cma.j.issn.1007-1245.2022.20.022

国际医药卫生导报 ›› 2022, Vol. 28 ›› Issue (20): 2915-2918.DOI: 10.3760/cma.j.issn.1007-1245.2022.20.022

排石汤对肾结石手术治疗患者的疗效研究

尹金阁

南阳医学高等专科学校第一附属医院普通外科六病区，南阳　473000

收稿日期:2022-08-12 出版日期:2022-10-15 发布日期:2022-10-14
通讯作者: Email: yinjingee@126.com
基金资助:
河南省医学科技攻关项目（2019003761）

Curative effect of Paishi decoction in patients with renal calculi treated by surgery

尹金阁

The Sixth Ward of General Surgery, The First Affiliated Hospital of Nanyang Medical College, Nanyang 473000, China

Received:2022-08-12 Online:2022-10-15 Published:2022-10-14
Contact: yinjingee@126.com
Supported by:
Henan Province Medical Science and Technology Project (2019003761)

摘要/Abstract

摘要： 目的　观察肾结石手术患者术后应用排石汤辅助治疗的效果。方法　以南阳医学高等专科学校第一附属医院2021年4月至2022年4月期间接受手术治疗的110例肾结石患者为研究对象，经抽签法将其分为对照组和研究组，各55例。对照组男30例、女25例，年龄（55.23±2.26）岁，术后予以常规西药辅助排石；研究组男32例、女23例，年龄（55.19±2.47）岁，术后予以口服排石汤辅助治疗。比较两组的残留结石排出时间、结石清除时间、肾功能指标、炎症因子指标及术后并发症发生情况。采用独立样本t检验、χ²检验。结果　研究组残留结石排出时间、结石清除时间分别为（4.14±0.23）d、（7.05±0.16）d，均短于对照组的（5.95±0.56）d、（8.82±0.72）d，结石清除率为92.73%（51/55），高于对照组的81.82%（45/55），差异均有统计学意义（均P<0.05）。研究组血清肌酐（SCr）、血清尿素氮（BUN）、血清尿酸（UA）、白细胞介素-6（IL-6）、降钙素原（PCT）、C-反应蛋白（CRP）、肿瘤坏死因子-α（TNF-α）水平分别为（72.35±5.18）μmol/L、（4.17±0.25）mmol/L、（271.45±10.36）μmol/L、（125.45±5.28）ng/L、（0.32±0.11）μg/L、（7.13±0.25）mg/L、（1.22±0.35）μg/L，均低于对照组的（77.44±5.84）μmol/L、（5.88±0.62）mmol/L、（299.71±10.49）μmol/L、（140.36±5.37）ng/L、（0.67±0.36）μg/L、（9.44±0.37）mg/L、（2.71±0.26）μg/L，肾小球滤过率（EGFR）为（92.24±5.15）ml/min，高于对照组的（83.14±5.26）ml/min，差异均有统计学意义（均P<0.05）。研究组术后并发症发生率为9.09%（5/55），低于对照组20.00%（11/55），差异有统计学意义（P<0.05）。结论　在肾结石患者术后通过相应药物辅助可促进残留结石排出，相较于西药来说，中药排石汤对加快患者结石排出、清除，增强肾功能并缓解炎性反应均有积极意义，排石汤的促排石效果好，可避免患者术后发生相关并发症，可更好适应患者临床需求。

关键词: 肾结石, 术后排石, 排石汤, 炎症因子, 肾功能

Abstract: Objective　To observe the effect of Paishi decoction as an adjuvant therapy for patients with renal calculi after surgery. Methods　A total of 110 patients with renal calculi who received surgical treatment in The First Affiliated Hospital of Nanyang Medical College from April 2021 to April 2022 were selected as the study subjects, and were divided into a control group and a study group by the lottery. In the control group, 30 males and 25 females, aged (55.23±2.26) years, were given conventional western medicine to assist stone removal after surgery; in the study group, 32 males and 23 females, aged (55.19±2.47) years, were treated with oral Paishi decoction. The residual stone removal time, stone removal time, renal function indexes, inflammatory factor indexes, and postoperative complications of the two groups were compared. Independent sample t test and χ² test were used. Results　The residual stone removal time and stone removal time of the study group were (4.14±0.23) d and (7.05±0.16) d, which were shorter than those of the control group [(5.95±0.56) d and (8.82±0.72) d], and the stone clearance rate was 92.73% (51/55), which was higher than that of the control group [81.82% (45/55)], with statistically significant differences (all P<0.05). The levels of serum creatinine (SCr), serum urea nitrogen (BUN), serum uric acid (UA), interleukin-6 (IL-6), procalcitonin (PCT), C-reactive protein (CRP), and tumor necrosis factor-α (TNF-α) in the study group were (72.35±5.18) μmol/L, (4.17±0.25) mmol/L, (271.45±10.36) μmol/L, (125.45±5.28) ng/L, (0.32±0.11) μg/L, (7.13±0.25) mg/L, and (1.22±0.35) μg/L, which were lower than those in the control group [(77.44±5.84) μmol/L, (5.88±0.62) mmol/L, (299.71±10.49) μmol/L, (140.36±5.37) ng/L, (0.67±0.36) μg/L, (9.44±0.37) mg/L, and (2.71±0.26) μg/L], the glomerular filtration rate (EGFR) was (92.24±5.15) ml/min, which was higher than that in the control group [(83.14±5.26) ml/min], with statistically significant differences (all P<0.05). The incidence of postoperative complications in the study group was 9.09% (5/55), which was lower than 20.00% (11/55) in the control group, with a statistically significant difference (P<0.05). Conclusions　In patients with renal calculi after surgery, the assistance of corresponding drugs can promote the removal of residual stones. Compared with western medicine, Paishi decoction has a positive significance in accelerating the removal of stones in patients, enhancing the renal function, and relieving the inflammatory reaction. Paishi decoction has a good effect of promoting stone removal, can avoid the postoperative complications, and can better meet patients' clinical needs.

Key words: 肾结石, 术后排石, 排石汤, 炎症因子, 肾功能

尹金阁. 排石汤对肾结石手术治疗患者的疗效研究[J]. 国际医药卫生导报, 2022, 28(20): 2915-2918.

尹金阁. Curative effect of Paishi decoction in patients with renal calculi treated by surgery[J]. International Medicine and Health Guidance News, 2022, 28(20): 2915-2918.

参考文献

[1] 邱瑾. 肾结石发病机制的研究进展[J]. 国际泌尿系统杂志,2020,40(4):750-753.DOI:10.3760/cma.j.cn431460- 20190408-00054.
[2] Wang Z, Zhang Y, Zhang J, et al. Recent advances on the mechanisms of kidney stone formation (Review)[J].Int J Mol Med,2021,48(2):149.DOI:10.3892/ijmm.2021.4982.
[3] Zisman AL, Coe FL, Cohen AJ, et al. Racial Differences in Risk Factors for Kidney Stone Formation[J].Clin J Am Soc Nephrol,2020,15(8):1166-1173.DOI:10.2215/CJN.12671019.
[4] 彭畔新,赵航,张冠. 无症状肾结石的处理方式:主动监测、药物溶石、微创治疗?[J]. 微创泌尿外科杂志,2020,9(3):208-211.DOI:10.19558/j.cnki.10-1020/r.2020.03.012.
[5] 王青富,张玉,郭建功,等. 体外震波碎石术后联合中药排石汤治疗肾结石对红细胞免疫功能、排石效果的影响[J]. 中华中医药学刊,2020,38(12):91-93. DOI:10.13193/j.issn.1673-7717.2020.12.025.
[6] 储传敏,张鹤,王磊,等. 2019年泌尿系统结石诊治进展[J]. 上海医学,2020,43(6):341-346.DOI:10.19842/j.cnki.issn.0253-9934.2020.06.006.
[7] Bayne DB, Armas-Phan M, Srirangapatanam S, et al. Low urologist density predicts high-cost surgical treatment of stone disease[J].J Endourol,2021,35(4):552-559.DOI:10.1089/end.2020.0676.
[8] Paludo AO, Gorgen ARH, Araldi M, et al. Laparoscopic pielolitotomy: an option for the management of pelvic kidney stones[J].Int Braz J Urol,2020,46(3):489-490. DOI:10.1590/S1677-5538.IBJU.2019.0148.
[9] 沈学成,孙静,熊朝晖,等. 联合取石术与经皮肾镜取石术治疗输尿管上段结石合并同侧肾结石的疗效分析[J]. 微创泌尿外科杂志,2021,10(4):238-242.DOI:10.19558/j.cnki.10- 1020/r.2021.04.005.
[10] 熊庄,程帆. 微通道经皮肾镜取石术用于不同类型肾结石的临床应用进展[J]. 中国医药导报,2022,19(4):57-61.
[11] 王毅敏. 坦索罗辛应用于输尿管结石合并前列腺良性肿瘤经体外冲击波碎石术后的临床效果及预后影响[J]. 中华肿瘤防治杂志,2018,25(s1):114,116.DOI:10.16073/j.cnki.cjcpt.2018.s1.052.
[12] 唐琪琳,年莉. 中医药治疗肾结石的现代研究概况[J]. 西部中医药,2020,33(3):146-150.DOI:10.12174/j.issn.1004-6852.2020.03.42.
[13] 陈曙辉,任毅轩,曹继刚. 基于网络药理学探析金钱草作为石淋要药治疗肾结石的作用机制研究[J]. 中国中西医结合肾病杂志,2021,22(4):340-344,后插1. DOI:10.3969/j.issn.1009-587X.2021.04.017.
[14] 黄丽,孙晓静,孙治中,等. 基于网络药理学预测金钱草治疗泌尿系结石的作用机制[J]. 广州中医药大学学报,2020,37(11):2174-2179. DOI:10.13359/j.cnki.gzxbtcm.2020. 11.023.
[15] 黎辉,耿仁刚,胡威.排石汤加减联合经皮肾镜取石术治疗肾结石效果及对炎症因子及尿激酶、甲状腺素表达水平的影响[J].世界中西医结合杂志,2020,15(9):1581-1585.DOI:10.13935/j.cnki.sjzx.200904.

排石汤对肾结石手术治疗患者的疗效研究

Curative effect of Paishi decoction in patients with renal calculi treated by surgery

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 9

编辑推荐

Metrics

[1]	索敬钧, 杨青彦, 李涛, 韩健乐, 杨俊伟, 王长安, 杨帅平. 含西罗莫司的四联免疫抑制剂方案对肾移植术后患者肾功能、T淋巴细胞亚群及预后的影响[J]. 国际医药卫生导报, 2022, 28(6): 752-755.
[2]	杜江涛李扬欧阳山丹刘炳震林珍. 替加环素联合头孢哌酮舒巴坦治疗ICU重度腹腔感染的效果[J]. 国际医药卫生导报, 2022, 28(21): 3077-3081.
[3]	林馥嘉, 欧财文, 柯培锋, 陈曲波, 徐建华. 柠檬乌梅提取液预防肾草酸钙结石作用机制的研究[J]. 国际医药卫生导报, 2022, 28(2): 171-175.
[4]	周珊汕, 吴智丹. 急性肾功能衰竭患者的综合护理干预分析[J]. 国际医药卫生导报, 2022, 28(2): 278-280.
[5]	苏高彦郭洁. 品管圈气道管理联合临床护理路径干预在重症肺炎患儿中的应用观察[J]. 国际医药卫生导报, 2022, 28(16): 2307-2310.
[6]	徐立娜　王文颖 . 补肾祛瘀活血汤治疗慢性肾小球肾炎患者的效果分析[J]. 国际医药卫生导报, 2022, 28(16): 2335-2338.
[7]	嵇高德, 姜莉华, 李群. 达格列净治疗2型糖尿病的效果分析[J]. 国际医药卫生导报, 2022, 28(11): 1579-1583.
[8]	潘小龙, 李晓, 衡宝利, 朱光建, 黄振, 吴凡宇. 无管化与传统PCNL治疗肾、输尿管上段结石的临床研究[J]. 国际医药卫生导报, 2022, 28(10): 1377-1380.
[9]	车启富, 何丽杰, 沈忠达. 芪莲花解毒丸联合中药膏敷贴治疗肺炎患者的效果分析[J]. 国际医药卫生导报, 2022, 28(10): 1422-1426.